What our industry colleagues are saying
"The value of deeper clinical data, combined with predictive analytics, can deliver greater insights for life sciences companies to create more valuable customer interactions," said Ed Manko, director of Veeva OpenData strategy at Veeva Systems. "As a member of the Veeva OpenData Partner Program, Crossix and Veeva are working together to provide comprehensive and accurate data across the industry."
"In the past few years, our clients have made significant progress in better understanding the various milestones and nuances along the patient journey," said David Windhausen, executive vice president at Intouch Solutions. Advances in data and technology have been key to this progress, but questions still remain. Many of these questions can now be answered through this expanded, more comprehensive data set that enables a much more granular and holistic view into ever-changing patient dynamics."
"While claims data is certainly useful, there are also limitations when it comes to the granularity of insights you can glean from it," said Dori Cappola, SVP media at Klick Health. "By connecting a greater variety of clinical, lab results, and biologics data, we can track even more key patient milestones across the patient journey, like diagnoses, initial treatment, and adherence for instance, with greater precision and specificity."